Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1988-08-25
1993-06-15
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
5303915, 5303917, 530402, 530304, 534 10, 534 14, A61K 4902, A61K 4300, C07F 1300
Patent
active
052195554
ABSTRACT:
The invention relates to a method for labeling substances with--in particular radioactive--technetium or rhenium isotopes with the aid of N-substituted or C-substituted macrocyclic amine derivatives of the formula I and/or II ##STR1## in which R.sup.1 -R.sup.7, Y, m, n, o, p, f, g, h, i and j have the stated meanings, and to the use of these labeled substances, especially in medical diagnosis.
REFERENCES:
patent: 4678667 (1987-07-01), Meares et al.
patent: 4818813 (1989-04-01), Nowotnik et al.
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 5087696 (1992-02-01), Parker et al.
Franz, J. et al., "The Production of Tc-99m-Labeled . . . Chelating Agent", Nucl. Med. Biol., v. 14, No. 6, pp. 569-572, Jun. 1987.
Bremer Karl-Heinz
Kuhlmann Ludwig
Magerstadt Michael
Schwarz Alexander
Steinstrasser Axel
Hoechst Aktiengesellschaft
Sayala C.
Stoll Robert L.
LandOfFree
Method for labeling proteins with technetium or rhenium does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for labeling proteins with technetium or rhenium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for labeling proteins with technetium or rhenium will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1040744